Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

Megan Smith-Uffen, John Park, Andrew Parsonson, Anuradha Vasista

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	A03
Number of pages	2
Journal	Cancer Immunology Research
Volume	10
Issue number	12 Supplement
DOIs	https://doi.org/10.1158/2326-6074.TUMIMM22-A03
Publication status	Published - 1 Dec 2022
Externally published	Yes
Event	AACR Special Conference on Tumor Immunology and Immunotherapy - Boston, United States Duration: 21 Oct 2022 → 24 Oct 2022

Access to Document

@article{27c2ac779a85432da76106e10db571b0,

title = "Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy",

author = "Megan Smith-Uffen and John Park and Andrew Parsonson and Anuradha Vasista",

year = "2022",

month = dec,

day = "1",

doi = "10.1158/2326-6074.TUMIMM22-A03",

language = "English",

volume = "10",

journal = "Cancer Immunology Research",

issn = "2326-6066",

publisher = "AMER ASSOC CANCER RESEARCH",

number = "12 Supplement",

note = "AACR Special Conference on Tumor Immunology and Immunotherapy ; Conference date: 21-10-2022 Through 24-10-2022",

}

TY - JOUR

T1 - Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

AU - Smith-Uffen, Megan

AU - Park, John

AU - Parsonson, Andrew

AU - Vasista, Anuradha

PY - 2022/12/1

Y1 - 2022/12/1

U2 - 10.1158/2326-6074.TUMIMM22-A03

DO - 10.1158/2326-6074.TUMIMM22-A03

M3 - Meeting abstract

SN - 2326-6066

VL - 10

JO - Cancer Immunology Research

JF - Cancer Immunology Research

IS - 12 Supplement

M1 - A03

T2 - AACR Special Conference on Tumor Immunology and Immunotherapy

Y2 - 21 October 2022 through 24 October 2022

ER -